Mapping the incidence of drug‐induced liver injury: A systematic review and meta‐analysis
Journal of Digestive Diseases · 2023-05 · 24 (5) · 332-339
DOI: 10.1111/1751-2980.13205 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Digestive Diseases, online erschienen am 13.08.2023. Verfasst von Min Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology and Evidence Based Medicine Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute,…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
Drug‐induced liver injury (DILI) is an increasing etiology of liver dysfunction, with various incidence worldwide. To better understand the disease burden and establish appropriate preventive and treatment strategies, a systematic review and meta‐analysis was conducted.
Methods
PubMed, EMBASE, Web of Science, and Cochrane Library were searched for studies on the incidence of DILI published up to June 1, 2022. According to the predefined criteria, only population‐based studies were included. Incidence was presented as cases per 100 000 person‐years with 95% confidence interval (CI) using a random‐effects model.
Results
A total of 14 studies were included. The overall incidence of DILI was 4.94 per 100 000 person‐years (95% CI 4.05–5.83). Time‐based cumulative meta‐analysis suggested that the incidence of DILI increased over time since 2010. The incidence varied by regions, with Asia having the highest incidence of 17.82 per 100 000 person‐years (95% CI 6.26–29.38), while North America having the lowest incidence of 1.72 per 100 000 person‐years (95% CI 0.48–2.95). All studies reported a higher incidence of DILI in the elderly but comparable incidences between male and female (3.42 per 100 000 person‐years vs 4.64 per 100 000 person‐years).
Conclusions
The global incidence of DILI has been increasing since 2010, with the highest incidence in Asia. Understanding the epidemiological characteristics of DILI helps establish specific strategies to deal with this emerging health problems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Epidemiology and Evidence Based Medicine Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China.
- Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Xin Yan Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, M., Wang, Y., Lv, T. T., Liu, J. M., Kong, Y. Y., Jia, J. D., & Zhao, X. Y. (2023). Mapping the incidence of drug‐induced liver injury: A systematic review and meta‐analysis. Journal of Digestive Diseases, 24(5), 332-339. https://doi.org/10.1111/1751-2980.13205
Vancouver
Li M, Wang Y, Lv TT, Liu JM, Kong YY, Jia JD, et al. Mapping the incidence of drug‐induced liver injury: A systematic review and meta‐analysis. Journal of Digestive Diseases. 2023;24(5):332-339. doi:10.1111/1751-2980.13205
BibTeX
@article{Li2023,
author = {Li, Min and Wang, Yu and Lv, Ting Ting and Liu, Ji Min and Kong, Yuan Yuan and Jia, Ji Dong and Zhao, Xin Yan},
title = {Mapping the incidence of drug‐induced liver injury: A systematic review and meta‐analysis},
journal = {Journal of Digestive Diseases},
year = {2023},
volume = {24},
number = {5},
pages = {332--339},
doi = {10.1111/1751-2980.13205}
}
EUVIMED